X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs GLENMARK PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS GLENMARK PHARMA J.B.CHEMICALS/
GLENMARK PHARMA
 
P/E (TTM) x 17.7 22.5 78.8% View Chart
P/BV x 2.4 3.5 68.1% View Chart
Dividend Yield % 0.2 0.3 47.1%  

Financials

 J.B.CHEMICALS   GLENMARK PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
GLENMARK PHARMA
Mar-17
J.B.CHEMICALS/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs318993 32.0%   
Low Rs200729 27.4%   
Sales per share (Unadj.) Rs148.0325.5 45.5%  
Earnings per share (Unadj.) Rs19.139.3 48.6%  
Cash flow per share (Unadj.) Rs23.948.7 49.2%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.2 83.2%  
Book value per share (Unadj.) Rs128.9159.2 81.0%  
Shares outstanding (eoy) m84.82282.17 30.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.72.6 66.1%   
Avg P/E ratio x13.621.9 61.9%  
P/CF ratio (eoy) x10.817.7 61.1%  
Price / Book Value ratio x2.05.4 37.1%  
Dividend payout %2.65.1 51.5%   
Avg Mkt Cap Rs m21,951242,991 9.0%   
No. of employees `0002.713.0 21.1%   
Total wages/salary Rs m1,84116,408 11.2%   
Avg. sales/employee Rs Th4,590.97,083.9 64.8%   
Avg. wages/employee Rs Th673.41,265.4 53.2%   
Avg. net profit/employee Rs Th592.1855.1 69.2%   
INCOME DATA
Net Sales Rs m12,55191,857 13.7%  
Other income Rs m542374 144.9%   
Total revenues Rs m13,09392,230 14.2%   
Gross profit Rs m2,05520,367 10.1%  
Depreciation Rs m4122,644 15.6%   
Interest Rs m962,373 4.0%   
Profit before tax Rs m2,08815,724 13.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m4693,827 12.3%   
Profit after tax Rs m1,61911,088 14.6%  
Gross profit margin %16.422.2 73.8%  
Effective tax rate %22.524.3 92.3%   
Net profit margin %12.912.1 106.8%  
BALANCE SHEET DATA
Current assets Rs m7,77868,746 11.3%   
Current liabilities Rs m4,35827,027 16.1%   
Net working cap to sales %27.245.4 60.0%  
Current ratio x1.82.5 70.2%  
Inventory Days Days5585 64.3%  
Debtors Days Days8096 83.8%  
Net fixed assets Rs m5,71324,132 23.7%   
Share capital Rs m170282 60.1%   
"Free" reserves Rs m10,54744,643 23.6%   
Net worth Rs m10,93744,925 24.3%   
Long term debt Rs m045,363 0.0%   
Total assets Rs m15,574117,639 13.2%  
Interest coverage x22.87.6 299.3%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.80.8 103.2%   
Return on assets %11.011.4 96.2%  
Return on equity %14.824.7 60.0%  
Return on capital %20.019.1 104.3%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16956,152 11.0%   
Fx outflow Rs m1,2858,084 15.9%   
Net fx Rs m4,88448,068 10.2%   
CASH FLOW
From Operations Rs m1,3976,574 21.2%  
From Investments Rs m-320-7,124 4.5%  
From Financial Activity Rs m-1,1965,432 -22.0%  
Net Cashflow Rs m-1021,992 -5.1%  

Share Holding

Indian Promoters % 55.4 48.3 114.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 6.9 49.1%  
FIIs % 3.9 34.4 11.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 56,727 53.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 30.1% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, GLENMARK PHARMA has posted a net profit of Rs 2 bn (down 30.1% YoY). Sales on the other hand came in at Rs 22 bn (down 8.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.6% (Quarterly Result Update)

May 31, 2018 | Updated on May 31, 2018

For the quarter ended March 2018, GLENMARK PHARMA has posted a net profit of Rs 2 bn (down 6.6% YoY). Sales on the other hand came in at Rs 23 bn (down 7.2% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 14, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - UNICHEM LAB COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS